Treatment of HER2-positive breast cancer

The Breast : Official Journal of the European Society of Mastology
Maria Cristina Figueroa-MagalhãesAntonio C Wolff

Abstract

The human epidermal growth factor receptor 2 gene (HER2) is overexpressed and/or amplified in ~15% of breast cancer patients and was identified a quarter century ago as a marker of poor prognosis. By 1998, antibody therapy targeting the HER2 pathway was shown to demonstrably improve progression-free and overall survival in metastatic disease, and in 2005 evidence of improvement in disease-free and overall survival from the first generation of trastuzumab adjuvant trials became available. However, not all patients with HER2 overexpression benefit from trastuzumab. Second-generation studies in metastatic disease led to the approval of several new HER2-targeted therapies using small molecule tyrosine kinase inhibitors such as lapatinib, new HER2/HER3 antibodies such as pertuzumab, and the new antibody chemotherapy conjugate ado-trastuzumab emtansine. These successes supported the launch of second-generation adjuvant trials testing single and dual HER2-targeted agents, administered concomitantly or sequentially with chemotherapy that will soon complete accrual. HER2-positive breast cancer in the setting of HER2-targeted therapy is no longer associated with poor prognosis, and recent guidance by the US Food and Drug Administration s...Continue Reading

References

Aug 15, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D GancbergD Larsimont
Jun 15, 2004·Proceedings of the National Academy of Sciences of the United States of America·Songdong MengJonathan Uhr
Oct 28, 2005·The New England Journal of Medicine·Donald A BerryUNKNOWN Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators
Jun 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nicholas RobertDennis Slamon
Dec 29, 2006·The New England Journal of Medicine·Charles E GeyerDavid Cameron
Jun 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gerhard SchallerNikola Bangemann
Aug 8, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rupert BartschGuenther G Steger
Mar 28, 2008·The New England Journal of Medicine·Soonmyung PaikNorman Wolmark
Oct 29, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Angelo Di LeoMichael F Press
Nov 18, 2008·Cancer Research·Gail D Lewis PhillipsMark X Sliwkowski
Sep 30, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen JohnstonMark Pegram
Nov 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ana M Gonzalez-AnguloGabriel N Hortobagyi
Nov 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giuseppe CuriglianoAron Goldhirsch
Nov 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Heikki JoensuuPirkko-Liisa Kellokumpu-Lehtinen
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marc SpielmannFrédérique Penault-Llorca
Feb 4, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·José BaselgaLuca Gianni
Feb 4, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kimberly L BlackwellJoyce O'Shaughnessy
Feb 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harold J BursteinRajendra Badwe
Mar 24, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael UntchGunter von Minckwitz
Apr 28, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ian E KropHoward A Burris
Aug 11, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edith A PerezRobert B Jenkins
Nov 3, 2010·The Oncologist·Lajos PusztaiClifford A Hudis
Dec 4, 2010·The Lancet Oncology·Susana Banerjee, Ian E Smith
Dec 22, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Howard A BurrisJoyce A O'Shaughnessy
Apr 13, 2011·Proceedings of the National Academy of Sciences of the United States of America·John StaggMark J Smyth
Jul 12, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Gunter von MinckwitzUNKNOWN GBG 26/BIG 03-05 study group and participating investigators
Jul 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edith A PerezNorman Wolmark

❮ Previous
Next ❯

Citations

Sep 22, 2016·Indian Journal of Surgical Oncology·Hemanga Kumar BhattacharjeeMahesh C Misra
Jan 19, 2016·American Journal of Preventive Medicine·Donatus U Ekwueme, Justin G Trogdon
Jan 24, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A S ClarkD Mankoff
Mar 5, 2016·Cancer Investigation·Ya-Bing ZhengXi-Ping Zhang
Sep 1, 2015·Critical Reviews in Oncology/hematology·María Teresa MartínezAna Lluch
Jun 5, 2015·Breast Cancer Research : BCR·Greg J LoganPriscilla F McAuliffe
May 9, 2015·Seminars in Oncology Nursing·Brygida Berse, Julie A Lynch
Jul 1, 2016·Journal of Experimental & Clinical Cancer Research : CR·Alessandra FabiFrancesco Cognetti
Aug 20, 2016·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Yunting ZhuDafang Zhong
Aug 20, 2016·Clinical and Translational Medicine·Marek MaleckiXenia Tombokan
Jan 25, 2017·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Xin LiLianshan Zhang
Aug 12, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elena B Elkin, Clifford A Hudis
Apr 10, 2018·Journal of Physics D: Applied Physics·Linda OswaldJosef A Käs
Sep 8, 2018·Journal of Comparative Effectiveness Research·Omar Abdel-Rahman
Sep 25, 2017·Journal of the American Heart Association·Roberta FloridoStuart D Russell
Jan 17, 2019·Archives of Pharmacal Research·Eunae Sandra ChoJong In Yook
May 9, 2019·Cancers·Nur Izyani KamaruzmanEzharul Hoque Chowdhury
Jul 12, 2018·Current Cancer Drug Targets·Peng LiuXiangsheng Xiao
Sep 29, 2019·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Hiba ZalloumMalek Zihlif
Nov 22, 2019·Experimental & Molecular Medicine·Hongming SongLin Fang
Mar 15, 2020·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Arezoo SaeiMoones Rahmandoust
Feb 16, 2017·Oncotarget·Fu-Chao LiuHuang-Ping Yu
Dec 7, 2019·Oncology Letters·Giovanna Rossi VaralloDebora Aparecida Pires De Campos Zuccari
Sep 1, 2019·Alzheimer's Research & Therapy·Jeffrey CummingsPhilip Scheltens
Sep 10, 2016·World Journal of Gastroenterology : WJG·Chiara CaparelloElisa Giovannetti
Nov 17, 2017·Breast Cancer Research and Treatment·Omar Abdel-Rahman
Nov 23, 2019·Journal of Enzyme Inhibition and Medicinal Chemistry·Faez Iqbal KhanMohd Kalim Ahmad Khan
Aug 9, 2020·Cancer Medicine·Demetria Smith-GrazianiMariana Chavez-MacGregor

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Related Papers

Biologics : Targets & Therapy
Hikmat Abdel-Razeq, Lina Marei
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Jean-Christophe TheryFrédérique Penault Llorca
© 2021 Meta ULC. All rights reserved